GlassScriptPhysician profile
Aidan D Hamm
NPI 1275976839
$30,430.26
in general payments reported to CMS, 2019-2025
31 companies · $607 in 2025
The $607 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,201 · 2020: $10K · 2021: $953 · 2022: $12K · 2023: $3,131 · 2024: $2,062 · 2025: $607.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,429 · Travel and Lodging: $1,371.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,429.09 |
| Travel and Lodging | $1,371.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $10,140.87 | 2019-2020 | |
| Intuitive Surgical, INC. | $9,098.89 | 2022-2023 | Da Vinci Surgical System |
| Penumbra, INC. | $2,962.08 | 2020-2025 | Indigo System, Penumbra System |
| W. L. Gore & Associates, INC. | $2,149.88 | 2021-2025 | Gore Excluder Aaa Endoprosthesis, Gore Excluder Thoracoabdominal Branch Endoprosthesis, Gore Viabahn Vbx Balloon Expandable Endo |
| Endologix LLC | $1,647.58 | 2021-2023 | |
| Shockwave Medical, INC | $684.46 | 2020-2022 | |
| Cvrx, INC. | $624.01 | 2023-2025 | Barostim Neo System |
| Silk Road Medical, INC. | $578.39 | 2019-2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| Medtronic, INC. | $371.13 | 2021-2025 | Endurant Iis, Chameleon, Heli-Fx Endoanchor System |
| Bolton Medical INC | $348.12 | 2022-2024 | Relay Thoracic Stent-Graft With Plus Delivery System |
| Boston Scientific Corporation | $314.45 | 2019-2022 | |
| Philips North America LLC | $279.10 | 2020-2024 | (Br5) Peripheral Ivus |
| Getinge USA Sales, LLC | $225.30 | 2019-2020 | |
| Integra Lifesciences Corporation | $212.92 | 2023-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Davol INC. | $157.53 | 2023-2025 | Phasix Mesh |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiva Medical, INC. | $126.04 | 2022-2025 | Cardiva Vascade 6/7f Vcs |
| Bard Peripheral Vascular, INC. | $123.93 | 2019 | |
| Inari Medical, INC. | $55.81 | 2021 | |
| Tela Bio, INC. | $42.55 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Sirtex Medical INC | $41.84 | 2024 | Lava Les (Liquid Embolic System) |
| Janssen Pharmaceuticals, INC | $36.51 | 2021-2022 | |
| Kerecis Limited | $31.30 | 2022-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Dilon Technologies, INC. | $25.75 | 2023 | Hemoblast Bellows |
| Conmed Corporation | $24.41 | 2024 | Airseal, Conmed Handheld Instruments |
| Organogenesis INC. | $24.08 | 2024 | |
| Acera Surgical, INC. | $22.65 | 2025 | Restrata Wound Matrix |
| Cardiovascular Systems INC. | $21.12 | 2019 | |
| Becton, Dickinson and Company | $15.63 | 2024 | Venclose Maven Catheter |
| Solventum Corporation | $15.07 | 2024 | Activ.A.C., Promogran |
| Hologic Sales and Service, LLC | $15.07 | 2024 | Coolseal Generator |
| Biotissue Holdings INC. | $13.79 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aidan Hamm listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.